Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Tolerability of Long-Term Dilaudid SR in Cancer Pain
NCT00410787Phase 3Completed
- Sponsor
- ALZA Corporation
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of hydromorphone in cancer pain, sponsored by ALZA Corporation. Status: completed.
02
Drugs
hydromorphone
03
Conditions
cancer pain
Beyond the preview
Go deeper on NCT00410787.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00410787.